2016 New Frontiers in the Point-of-Care/POC Infectious Disease Testing Market: Business Challenges, Emerging Technologies, Competitive Landscape

“2016 New Frontiers in the Point-of-Care/POC Infectious Disease Testing Market” is VPGMarketResearch’s new report, which provides comprehensive analysis of the  POC infections disease testing market, including its dynamics, size, growth, regulatory requirements, technological trends, competitive landscape, and emerging opportunities for instrument and consumable suppliers.

Rationale

The growing economic pressures on hospitals, coupled with advances in diagnostic technologies, intensifying competition among suppliers and physicians, and changing consumer demands are shifting diagnostic testing from hospitals and commercial laboratories closer to the patient.

Market Segmentation

- Review of the POC market segments, including their dynamics, trends, structure, size, growth and major suppliers.

- Five-year test volume and reagent sales forecasts for major infectious disease tests by market segment:



- Physician Offices/Group Practices    

- Emergency Rooms       

- Ambulatory Care Centers        

- Surgery Centers 

- Birth Centers

Sales and Market Share Analysis

- Sales and market shares of major reagent and instrument suppliers.

Infectious Disease Tests

AIDS/HIV, Adenovirus, Aeromonads, Bartonella, Blastocystis Hominis, Campylobacter, Candida, Chancroid, Chlamydia, Clostridium, Coronavirus, Coxsackievirus, Cryptosporidium, Cyclospora, CMV, E. Coli, Echovirus,  Encephalitis, Enterovirus, EBV, Giardia, Gonorrhea, Granuloma Inguinale, Hantavirus, H. Pylori, Hepatitis (A, B, C, D, E), Herpes Simplex Virus, Human Herpes Virus-6 (HHV-6), Influenza, Legionella, Lyme disease, Pymphogranuloma, Malaria, Measles, Meningitis, Mononucleosis, Microsporidium, Mononucleosis, Mumps, Mycoplasma, Polyomaviruses, Parvovirus B19, Pneumonia, Polyomaviruses, Pseudomonas, Rabies, RSV, Rhinovirus, Rheumatoid Arthritis, Rotavirus , Rubella, Salmonellosis, Septicemia, Shigella, Staphylococci, Streptococci, Syphilis, Toxoplasmosis, Trichomonas, Tuberculois, Vibrio, West Nile, Yersenia.

Technology Review

- Emerging technologies and their applications for POC testing.

- Comprehensive listings of companies developing or marketing POC diagnostic technologies

  and products, by test.

Strategic Recommendations

- Specific opportunities for new POC instruments and reagent systems with potentially

  significant market appeal during the next five years.

- Design criteria for POC testing products.

- Alternative business expansion strategies.

- Potential market entry barriers and risks.

Competitive Assessments

- Assessments of major suppliers and emerging market entrants, including their sales, product

  portfolios, marketing tactics, joint ventures, and new products in R&D.

- The companies analyzed in the report include:

   - Abbott

   - Affymetrix

   - Beckman Coulter/Danaher

   - Becton Dickinson

   - Biomerieux

   - Bio-Rad

   - Cepheid       

   - Diamedix/Erba           

   - Diasorin

   - Eiken Chemical

   - Elitech Group

   - Enzo Biochem

   - Fujirebio

   - Grifols

   - Hologic/Gen-Probe

   - ID Biomedical/GSK

   - Kreatech/Leica

   - Lonza

   - Ortho-Clinical Diagnostics

   - Qiagen

   - Roche

   - Scienion

   - Sequenom

   - SeraCare

   - Siemens

   - Takara Bio

   - ThermoFisher

   - Wallac/PE

   - Wako

  

Methodology

This report is based on a combination of primary and secondary sources of information, including review of recent technical and business publications, manufacturer product literature, industry analyst reports, and VPGMarketResearch's proprietary data files.

Contains 835 pages and 80 tables